Skip to main content
Premium Trial:

Request an Annual Quote

Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products

NEW YORK (GenomeWeb News) — Invitrogen, saying it sees more researchers moving toward using synthetic genes over clones, today said it will exclusively distribute Blue Heron's synthetic gene products.
Through the agreement, Invitrogen said it will make an undisclosed investment in Blue Heron in exchange for exclusive worldwide distribution rights for the firm’s GeneMaker platform.
The agreement also allows the companies to co-develop new products and services, although Invitrogen did not offer more specifics about those plans.
According to Invitrogen, the synthetic gene platform made by Bothell, Wash-based Blue Heron can “synthesize any gene sequence,” making it “ideal for the synthetic biology market.”
Invitrogen said it believes the alliance will allow it to offer enhanced drug-discovery capabilities to its pharmaceutical and biotech clients.
Financial terms of the agreement were not disclosed.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.